This work developed an accessible, microscopy-based event-counting strategy that transduces miRNA targets into spatially discrete, countable fluorescence events, enabling reproducible quantification under a unified imaging and analysis framework on a standard widefield microscope.
Abstract
MicroRNAs (miRNAs) are key biomarkers for disease diagnosis and biological research, yet their reliable quantification in complex samples remains challenging. Fluorescence-based detection is often limited by heterogeneous amplification efficiency and the inherent variability of intensity-based readouts, making measurements vulnerable to both biochemical and optical fluctuations. Although digital approaches such as digital PCR can mitigate some of this variability, they pose a significant barrier to access due to their reliance on specialized micro-partitioning devices and instrumentation. To address this, we developed an accessible, microscopy-based event-counting strategy. Our design integrates a microlens array for optical signal enhancement with a surface-confined hybridization chain reaction (HCR). This configuration transduces miRNA targets into spatially discrete, countable fluorescence events, enabling reproducible quantification under a unified imaging and analysis framework on a standard widefield microscope. The assay demonstrates log-log linearity from 10 fM to 1 nM and achieves detection limits of 2.36-3.34 fM for three model miRNAs (miR-21, miR-122, and miR-155). In a 50% serum matrix, it maintains accurate quantification with recoveries of 93-112%. By shifting the readout from error-prone analog intensity measurements to robust event counting, this work provides a scalable and accessible platform for miRNA profiling.
Microribonucleic acids (microRNAs, miRNAs) are important emerging biomarkers, yet their detection in clinical samples remains challenging due to their low concentrations and matrix effects, which typically require complex workflows including miRNA extraction, reverse transcription, and amplification. Here, we introduce...
Jan Bukáček, Tomáš Špringer, Z. Krejčík et al.· Biosensors & bioelectronics· 0 citations
A highly sensitive fluorescent biosensor for miRNA-34a detection by integrating magnetic separation with cascade amplification of duplex-specific nuclease (DSN) and hybridization chain reaction (HCR) and showing excellent specificity for discriminating against interfering miRNAs is developed.
Yan-Jie Zheng, Xin-Yi Zhang, Si-Yi Wang et al.· Nanomedicine: Nanotechnology...· 0 citations
MicroRNAs (miRNAs) are crucial regulators in tumor development, so accurately detecting and imaging them in living cells is vital for early cancer diagnosis. However, their low levels inside cells and the complex cellular environment make traditional detection methods challenging. We developed a fluorescent sensing pla...
Hao Wu, Yu Wang, Jing-Yi Hao et al.· Organic and biomolecular che...· 0 citations
Modern clinical diagnostics require highly sensitive, rapid, and technologically simple methods for quantitatively determining biomarkers directly at the patient’s bedside. Fluorescence polarization (FP) meets these criteria, as it enables the homogeneous recording of an analytical signal based on changes in the rotati...
L. Mukhametova, S. Eremin, Andreas Tsakalof· Diagnostics· 0 citations
Accessible molecular diagnostics is fundamental to effective healthcare. While most current point-of-care devices detect only the presence of a molecular biomarker(s), biomarker quantification can be equally important for decision-making on disease treatment and containment. Here, we present a diagnostic platform that...
Multiplex pathogen detection is essential for addressing the increasing complexity of infectious diseases and co-infections, yet conventional polymerase chain reaction-based methods remain hindered by the requirement for sophisticated laboratory infrastructure. Isothermal amplification offers a robust alternative for p...
Yuan-Shou Zhu, Xi-Tian Xu, Yu-Xin Chen et al.· Progress in Medical Devices· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.